Dr. Fritz Wörwag GmbH

"WÖRWAG Pharma GmbH & Co. KG is a pharmaceutical company with subsidiaries worldwide. The company develops and sells biofactor preparations. The range of products of WÖRWAG Pharma comprises both prescription preparations and over the counter OTC products as well as food supplements. Most of the products, which are sold exclusively in pharmacies, are used to treat diabetic comorbidities such as neuropathy nerve damage as well as cardiovascular and neurological diseases. In 2018, the company with a staff of 900 employees in more than 35 countries achieved sales of 211 million euros. WÖRWAG Pharma is a family-owned company led by Monika Wörwag, Gerhard Mayer and Jochen Schlindwein."